🚨 New special issue now online 🚨
Read our latest special issue, which delves further into the different aspects surrounding #Vasculitis. The issue is freely available for everyone to read until next month.
Click here to read the full articles now ➡️ https://t.co/cuNRgs7SS1
Elevated Lipoprotein(a) is the latest variant of ‘bad cholesterol’ found to increase the risk of recurrent coronary heart disease.
Findings, published by @UNSWMedicine researchers in @CMRO_Journal, show it is an important CHD predictor in people 60+⚠️
https://t.co/VEtJdEtW2b
We are excited to share this recent supplement with everyone, which highlights the abstracts from the 17th Annual Cardiometabolic Health Congress (@CMHC_CME).
Click here to read the full supplement online ➡️ https://t.co/iQmvAzScnI #Cardiometabolic#Cardiovascular#Diabetes
Delighted to share a recent supplement, which has been published in Postgraduate Medicine, on "#Semaglutide for #weight management – an introduction for primary care."
Click here to read the full supplement ➡️ https://t.co/dIGxwbnpyK #WeightManagement#Obesity#PrimaryCare
The @NHF_Hemophilia State of the Science Research Summit and their national research blueprint for patient-centered care for inherited #bleedingdisorders is now published in Expert Review of Hematology!
Read it here: 👇
https://t.co/2Ckx1mLwo6
#hemophilia#healthequity
Finerenone: a mineralocorticoid receptor antagonist for the treatment of chronic kidney disease associated with type 2 diabetes ca. 2022 #Nephpearls
https://t.co/uzMpy4ddWP
We are excited to share this special focus issue on JAK inhibitors in autoimmune and inflammatory diseases in Expert Review of Clinical Immunology #immunology#rheumatology#jakinhibitors
https://t.co/Mvoo3P2KiU
Showcasing Science, the hub for ground-breaking science
See full articles come alive as animated infographics and discover videos and essential reading lists covering ground-breaking research #ShowcasingScience
https://t.co/IKNsf36jrh
#ShowcasingScience#OpenAccess
Discover more about our latest article, economic evaluation of polatuzumab-bendamustine-rituximab vs. tafasitamab-lenalidomide in transplant-ineligible R/R DLBCL, in this interview with the author Dr. Matthias Calamia. #oncology
Click the link for more: https://t.co/ZbPsiKOgq1
Over a month into my new role but I’m delighted to announce that I am the Commissioning Editor for “Expert Review of Clinical Pharmacology” & “Expert Opinion on Drug Metabolism and Toxicology”
I’m really looking forward to building and making new connections in these fields!
The Glossary for Advanced Therapies is here! This 5th and latest edition of our Glossary provides a comprehensive update on the field of #RegenerativeMedicine and #AdvancedTherapies.
Follow us and like this post to be in with a chance of winning a FREE physical copy!
@laratshering @paigeebryant @moksina@sheneilkbk I miss you so much as well! Thank you for always supporting me and uplifting me, whether it’s to do with work or personal obstacles! So much love for you today and every day 💜
Coming in with another #InternationalWomensDay interview, we have Dr Treena Arinzeh (@NJIT) on developing functional #biomaterials for tissue regeneration.
Click here to read the full feature on @RegMedNet >>> https://t.co/GVGr5FLvPE
Happy #InternationalWomensDay 🎉🎉
I've had the best time putting together this 'Women to Watch' interview series on both @Neuro_Central and @RegMedNet! There are A LOT and still more to come but I am too proud to not to create a thread for both sites 🧵
We also have this #InternationalWomensDay interview with Felicia Rosenthal, the CEO and Co-Founder of CellGenix, on enabling safe and efficient production of cell and gene therapies (#CGTs).
Take a look on @RegMedNet for the full piece >>> https://t.co/RV2JMGleoD